CAMBRIDGE, Mass., June 9 /CNW/ -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will webcast its presentations at three investor conferences: Pacific Growth Equities Life Sciences Growth Conference on Tuesday, June 13, 2006 at 10:30 a.m. PDT (1:30 p.m. EDT), presented by Ian Smith, Executive Vice President and Chief Financial Officer of Vertex Goldman Sachs 27th Annual Global Healthcare Conference on Wednesday, June 14, 2006 at 3:00 p.m. PDT (6:00 p.m. EDT), presented by Joshua Boger, Ph.D., President and Chief Executive Officer of Vertex Needham & Co. Fifth Annual Biotechnology and Medical Technology Conference on Thursday, June 15, 2006 at 8:30 a.m. EDT, presented by Lynne Brum, Vice President, Strategic Communications of Vertex Each presentation will be webcast live and may be accessed by visiting the Vertex website at http://www.vrtx.com. A replay of the webcasts will also be available on the Company's website for two weeks following the presentations. To access the webcasts, go to Vertex's website and select the desired presentation from the 'Events Calendar.' To ensure a timely connection, it is recommended that users register at least 15 minutes prior to the scheduled webcast. About Vertex Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is principally focused on viral diseases, inflammation, autoimmune diseases and cancer. In collaboration with GlaxoSmithKline, Vertex co-promotes the HIV protease inhibitor, Lexiva. Lexiva is a registered trademark of the GlaxoSmithKline group of companies. Vertex's press releases are available at http://www.vrtx.com. Vertex Contact: Lora Pike, Manager, Investor Relations, (617) 444-6755